Violations of the independent increment assumption when using generalized estimating equation in longitudinal group sequential trials
In phase 3 clinical trials, ethical and financial concerns motivate sequential analyses in which the data are analyzed prior to completion of the entire planned study. Existing group sequential software accounts for the effects of these interim analyses on the sampling density by assuming that the c...
Saved in:
Published in | Statistics in medicine Vol. 33; no. 29; pp. 5041 - 5056 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
20.12.2014
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0277-6715 1097-0258 1097-0258 |
DOI | 10.1002/sim.6306 |
Cover
Loading…
Abstract | In phase 3 clinical trials, ethical and financial concerns motivate sequential analyses in which the data are analyzed prior to completion of the entire planned study. Existing group sequential software accounts for the effects of these interim analyses on the sampling density by assuming that the contribution of subsequent increments is independent of the contribution from previous data. This independent increment assumption is satisfied in many common circumstances, including when using the efficient estimator. However, certain circumstances may dictate using an inefficient estimator, and the independent increment assumption may then be violated. Consequences of assuming independent increments in a setting where the assumption does not hold have not been previously explored. One important setting in which independent increments may not hold is the setting of longitudinal clinical trials. This paper considers dependent increments that arise because of heteroscedastic and correlated data in the context of longitudinal clinical trials that use a generalized estimating equation (GEE) approach. Both heteroscedasticity over time and correlation of observations within subjects may lead to departures from the independent increment assumption when using GEE. We characterize situations leading to greater departures in this paper. Despite violations of the independent increment assumption, simulation results suggest that operating characteristics of sequential designs are largely maintained for typically observed patterns of accrual, correlation, and heteroscedasticity even when using analyses that use standard software that depends on an independent increment structure. More extreme scenarios may require greater care to avoid departures from the nominal type I error rate and power. Copyright © 2014 John Wiley & Sons, Ltd. |
---|---|
AbstractList | In phase 3 clinical trials, ethical and financial concerns motivate sequential analyses in which the data are analyzed prior to completion of the entire planned study. Existing group sequential software accounts for the effects of these interim analyses on the sampling density by assuming that the contribution of subsequent increments is independent of the contribution from previous data. This independent increment assumption is satisfied in many common circumstances, including when using the efficient estimator. However, certain circumstances may dictate using an inefficient estimator, and the independent increment assumption may then be violated. Consequences of assuming independent increments in a setting where the assumption does not hold have not been previously explored. One important setting in which independent increments may not hold is the setting of longitudinal clinical trials. This paper considers dependent increments that arise because of heteroscedastic and correlated data in the context of longitudinal clinical trials that use a generalized estimating equation (GEE) approach. Both heteroscedasticity over time and correlation of observations within subjects may lead to departures from the independent increment assumption when using GEE. We characterize situations leading to greater departures in this paper. Despite violations of the independent increment assumption, simulation results suggest that operating characteristics of sequential designs are largely maintained for typically observed patterns of accrual, correlation, and heteroscedasticity even when using analyses that use standard software that depends on an independent increment structure. More extreme scenarios may require greater care to avoid departures from the nominal type I error rate and power. In phase 3 clinical trials, ethical and financial concerns motivate sequential analyses in which the data are analyzed prior to completion of the entire planned study. Existing group sequential software accounts for the effects of these interim analyses on the sampling density by assuming that the contribution of subsequent increments is independent of the contribution from previous data. This independent increment assumption is satisfied in many common circumstances, including when using the efficient estimator. However, certain circumstances may dictate using an inefficient estimator, and the independent increment assumption may then be violated. Consequences of assuming independent increments in a setting where the assumption does not hold have not been previously explored. One important setting in which independent increments may not hold is the setting of longitudinal clinical trials. This paper considers dependent increments that arise because of heteroscedastic and correlated data in the context of longitudinal clinical trials that use a generalized estimating equation (GEE) approach. Both heteroscedasticity over time and correlation of observations within subjects may lead to departures from the independent increment assumption when using GEE. We characterize situations leading to greater departures in this paper. Despite violations of the independent increment assumption, simulation results suggest that operating characteristics of sequential designs are largely maintained for typically observed patterns of accrual, correlation, and heteroscedasticity even when using analyses that use standard software that depends on an independent increment structure. More extreme scenarios may require greater care to avoid departures from the nominal type I error rate and power. Copyright © 2014 John Wiley & Sons, Ltd. In phase 3 clinical trials, ethical and financial concerns motivate sequential analyses in which the data are analyzed prior to completion of the entire planned study. Existing group sequential software accounts for the effects of these interim analyses on the sampling density by assuming that the contribution of subsequent increments is independent of the contribution from previous data. This independent increment assumption is satisfied in many common circumstances, including when using the efficient estimator. However, certain circumstances may dictate using an inefficient estimator, and the independent increment assumption may then be violated. Consequences of assuming independent increments in a setting where the assumption does not hold have not been previously explored. One important setting in which independent increments may not hold is the setting of longitudinal clinical trials. This paper considers dependent increments that arise because of heteroscedastic and correlated data in the context of longitudinal clinical trials that use a generalized estimating equation (GEE) approach. Both heteroscedasticity over time and correlation of observations within subjects may lead to departures from the independent increment assumption when using GEE. We characterize situations leading to greater departures in this paper. Despite violations of the independent increment assumption, simulation results suggest that operating characteristics of sequential designs are largely maintained for typically observed patterns of accrual, correlation, and heteroscedasticity even when using analyses that use standard software that depends on an independent increment structure. More extreme scenarios may require greater care to avoid departures from the nominal type I error rate and power.In phase 3 clinical trials, ethical and financial concerns motivate sequential analyses in which the data are analyzed prior to completion of the entire planned study. Existing group sequential software accounts for the effects of these interim analyses on the sampling density by assuming that the contribution of subsequent increments is independent of the contribution from previous data. This independent increment assumption is satisfied in many common circumstances, including when using the efficient estimator. However, certain circumstances may dictate using an inefficient estimator, and the independent increment assumption may then be violated. Consequences of assuming independent increments in a setting where the assumption does not hold have not been previously explored. One important setting in which independent increments may not hold is the setting of longitudinal clinical trials. This paper considers dependent increments that arise because of heteroscedastic and correlated data in the context of longitudinal clinical trials that use a generalized estimating equation (GEE) approach. Both heteroscedasticity over time and correlation of observations within subjects may lead to departures from the independent increment assumption when using GEE. We characterize situations leading to greater departures in this paper. Despite violations of the independent increment assumption, simulation results suggest that operating characteristics of sequential designs are largely maintained for typically observed patterns of accrual, correlation, and heteroscedasticity even when using analyses that use standard software that depends on an independent increment structure. More extreme scenarios may require greater care to avoid departures from the nominal type I error rate and power. |
Author | Shoben, Abigail B. Emerson, Scott S. |
Author_xml | – sequence: 1 givenname: Abigail B. surname: Shoben fullname: Shoben, Abigail B. email: Correspondence to: Abigail B. Shoben, Division of Biostatistics, College of Public Health, The Ohio State University, 249 Cunz Hall, 1841 Neil Ave, Columbus, OH, 43210, U.S.A., ashoben@cph.osu.edu organization: Division of Biostatistics, College of Public Health, The Ohio State University, OH, 43210, Columbus, U.S.A – sequence: 2 givenname: Scott S. surname: Emerson fullname: Emerson, Scott S. organization: Department of Biostatistics, University of Washington, WA, 98195, Seattle, U.S.A |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25224560$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1v1DAQhi1URLcFiV-ALHHhksUfsZ0cUaEfUlkOfJSb5U0mW5fE2dqOSnvnfzPbbYtAwGXGGj_zambePbITxgCEPOdszhkTr5Mf5loy_YjMOKtNwYSqdsiMCWMKbbjaJXspXTDGuRLmCdkVSohSaTYjP774sXfZjyHRsaP5HKgPLawBQ8j4biIMm5dLaRrWG5BenUOgU_JhRVcQILre30BLIWU_oBSW4XK61cR-2o9h5fPU-uB6uorjtKYJ_1HTYyFHjOkpedxhgmd3eZ98Pnz36eC4OP1wdHLw5rRoykrpouWubJdl3VSy09wx0ZRS6Up0UHetK5esbI3jSnay5A7KJW8cAGN1y7pK1E0n98mrre46jjhCynbwqYG-dwHGKVmuhVC1YlIh-vIP9GKcIu6QrOC6xnmMlv-jUAtnFnXFkXpxR03LAVq7jnioeG3vbUBgvgWaOKYUobONz7cXzNH53nJmNz5b9NlufP61yEPDveZf0GKLXvkerv_J2Y8n73_nfcrw_YF38ZvVRhplzxZH9uvbM3O4WEhs_QkBi8fh |
CODEN | SMEDDA |
CitedBy_id | crossref_primary_10_1177_0962280218773115 crossref_primary_10_1093_biomtc_ujaf020 crossref_primary_10_1177_17407745241304284 |
Cites_doi | 10.2307/2533218 10.2307/2532890 10.1080/01621459.1997.10473654 10.1001/jama.300.15.1774 10.1080/03610919408813210 10.2307/2533336 10.2307/2343787 10.2307/2530245 10.1093/biomet/73.1.13 10.1093/biomet/82.2.407 10.1080/01621459.1997.10473655 10.1093/biomet/83.4.779 10.1093/biomet/64.2.191 |
ContentType | Journal Article |
Copyright | Copyright © 2014 John Wiley & Sons, Ltd. Copyright Wiley Subscription Services, Inc. Dec 20, 2014 |
Copyright_xml | – notice: Copyright © 2014 John Wiley & Sons, Ltd. – notice: Copyright Wiley Subscription Services, Inc. Dec 20, 2014 |
DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
DOI | 10.1002/sim.6306 |
DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Statistics Public Health |
EISSN | 1097-0258 |
EndPage | 5056 |
ExternalDocumentID | 3510083751 25224560 10_1002_sim_6306 SIM6306 ark_67375_WNG_XDW7FNN3_6 |
Genre | article Journal Article Feature |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5RE 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AAHQN AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABIJN ABJNI ABOCM ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACPOU ACRPL ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUYR AFBPY AFFPM AFGKR AFWVQ AFZJQ AHBTC AHMBA AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AUFTA AZBYB AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BSCLL BY8 CS3 D-E D-F DCZOG DPXWK DR2 DRFUL DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P G-S G.N GNP GODZA H.T H.X HBH HGLYW HHY HHZ HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K ROL RX1 RYL SUPJJ SV3 TN5 UB1 V2E W8V W99 WBKPD WH7 WIB WIH WIK WJL WOHZO WQJ WXSBR WYISQ XBAML XG1 XV2 ZZTAW ~IA ~WT AEUQT AFPWT RWI WRC WUP WWH AAYXX AEYWJ AGQPQ AGYGG AMVHM CITATION CGR CUY CVF ECM EIF NPM AAMMB AEFGJ AGXDD AIDQK AIDYY K9. 7X8 |
ID | FETCH-LOGICAL-c4856-d1a4db49c83f61a02c435682fe9fda4b04d7a153f341ae4b1caee009d0f829cf3 |
IEDL.DBID | DR2 |
ISSN | 0277-6715 1097-0258 |
IngestDate | Thu Jul 10 20:43:57 EDT 2025 Sat Aug 16 22:20:57 EDT 2025 Sun Jul 13 03:46:42 EDT 2025 Thu Apr 03 07:04:08 EDT 2025 Thu Apr 24 23:02:57 EDT 2025 Tue Jul 01 03:28:06 EDT 2025 Wed Jan 22 16:19:25 EST 2025 Wed Mar 05 09:12:29 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 29 |
Keywords | group sequential methods independent increments clinical trials |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor Copyright © 2014 John Wiley & Sons, Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4856-d1a4db49c83f61a02c435682fe9fda4b04d7a153f341ae4b1caee009d0f829cf3 |
Notes | istex:53B3DED3E8970202F8F7C4296DA84A913DD7EBC9 ark:/67375/WNG-XDW7FNN3-6 ArticleID:SIM6306 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
PMID | 25224560 |
PQID | 1628562981 |
PQPubID | 48361 |
PageCount | 16 |
ParticipantIDs | proquest_miscellaneous_1622595035 proquest_journals_2169485763 proquest_journals_1628562981 pubmed_primary_25224560 crossref_citationtrail_10_1002_sim_6306 crossref_primary_10_1002_sim_6306 wiley_primary_10_1002_sim_6306_SIM6306 istex_primary_ark_67375_WNG_XDW7FNN3_6 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20 December 2014 |
PublicationDateYYYYMMDD | 2014-12-20 |
PublicationDate_xml | – month: 12 year: 2014 text: 20 December 2014 day: 20 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: New York |
PublicationTitle | Statistics in medicine |
PublicationTitleAlternate | Statist. Med |
PublicationYear | 2014 |
Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
References | Insightful Corporation. S+seqtrial. Insightful Corporation: Seattle, Washington, 2002. Lee SJ, Kim K, Tsiatis AA. Repeated significance testing in longitudinal clinical trials. Biometrika 1996; 83:779-789. Jennison C, Turnbull B. Group Sequential Methods with Applications to Clinical Trials. CRC Press: Boca Raton, FL, 2000. Jennison C, Turnbull BW. Group sequential analysis incorporating covariate information. Journal of the American Statistical Association 1997; 92:1330-1341. Armitage P, McPherson CK, Rowe BC. Repeated significance tests on accumulating data. Journal of the Royal Statistical Society, Series A, General 1969; 132:235-244. Crowder M. On the use of working correlation matrix in using generalized linear models for repeated measures. Biometrika 1995; 82:407-410. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35:549-556. Fitzmaurice GM. A caveat concerning independence estimating equations with multivariate binary data. Biometrics 1995; 51:309-317. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-22. Mancl LA, Leroux BG. Efficiency of regression estimates for clustered data. Biometrics 1996; 52:500-511. Scharfstein DO, Tsiatis AA, Robins JM. Semiparametric efficiency and its implications on the design and analysis of group sequential studies. Journal of the American Statistical Association 1997; 92:1342-1350. Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64:191-200. The MPS Research Unit. PEST (Planning and Evaluation of Sequential Trials). The MPS Research Unit, The University of Reading, Reading: U.K., 2000 Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, Thal LJ. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. Journal of the American Medical Association 2008; 300(15):1774-1783. The Cytel Software Corp. East. The Cytel Software Corp: Cambridge, Massachusetts, 2000. Pepe MS, Anderson GL. A cautionary note on inference for marginal regression models with longitudinal data and general correlated response data. Communications in Statistics Simulation and Computation 1994; 23:939-951. Lipsitz SR, Fitzmaurice GM, Orav EJ, Laird NM. Performance of generalized estimating equations in practical situations. Biometrics 1994; 50:270-278. 1995; 51 1995; 82 1979; 35 1997; 92 1986; 73 2000 1994; 23 1996; 83 1996; 52 1977; 64 2002 2008; 300 1994; 50 1969; 132 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_15_1 The Cytel Software Corp (e_1_2_8_2_1) 2000 The MPS Research Unit (e_1_2_8_3_1) 2000 e_1_2_8_5_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_10_1 e_1_2_8_11_1 e_1_2_8_12_1 Jennison C (e_1_2_8_16_1) 2000 Insightful Corporation (e_1_2_8_4_1) 2002 |
References_xml | – reference: Mancl LA, Leroux BG. Efficiency of regression estimates for clustered data. Biometrics 1996; 52:500-511. – reference: Scharfstein DO, Tsiatis AA, Robins JM. Semiparametric efficiency and its implications on the design and analysis of group sequential studies. Journal of the American Statistical Association 1997; 92:1342-1350. – reference: Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-22. – reference: Crowder M. On the use of working correlation matrix in using generalized linear models for repeated measures. Biometrika 1995; 82:407-410. – reference: Lipsitz SR, Fitzmaurice GM, Orav EJ, Laird NM. Performance of generalized estimating equations in practical situations. Biometrics 1994; 50:270-278. – reference: Armitage P, McPherson CK, Rowe BC. Repeated significance tests on accumulating data. Journal of the Royal Statistical Society, Series A, General 1969; 132:235-244. – reference: O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35:549-556. – reference: Jennison C, Turnbull B. Group Sequential Methods with Applications to Clinical Trials. CRC Press: Boca Raton, FL, 2000. – reference: Jennison C, Turnbull BW. Group sequential analysis incorporating covariate information. Journal of the American Statistical Association 1997; 92:1330-1341. – reference: The Cytel Software Corp. East. The Cytel Software Corp: Cambridge, Massachusetts, 2000. – reference: Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, Thal LJ. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. Journal of the American Medical Association 2008; 300(15):1774-1783. – reference: The MPS Research Unit. PEST (Planning and Evaluation of Sequential Trials). The MPS Research Unit, The University of Reading, Reading: U.K., 2000 – reference: Fitzmaurice GM. A caveat concerning independence estimating equations with multivariate binary data. Biometrics 1995; 51:309-317. – reference: Insightful Corporation. S+seqtrial. Insightful Corporation: Seattle, Washington, 2002. – reference: Lee SJ, Kim K, Tsiatis AA. Repeated significance testing in longitudinal clinical trials. Biometrika 1996; 83:779-789. – reference: Pepe MS, Anderson GL. A cautionary note on inference for marginal regression models with longitudinal data and general correlated response data. Communications in Statistics Simulation and Computation 1994; 23:939-951. – reference: Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64:191-200. – volume: 83 start-page: 779 year: 1996 end-page: 789 article-title: Repeated significance testing in longitudinal clinical trials publication-title: Biometrika – volume: 92 start-page: 1330 year: 1997 end-page: 1341 article-title: Group sequential analysis incorporating covariate information publication-title: Journal of the American Statistical Association – volume: 300 start-page: 1774 issue: 15 year: 2008 end-page: 1783 article-title: High‐dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial publication-title: Journal of the American Medical Association – volume: 51 start-page: 309 year: 1995 end-page: 317 article-title: A caveat concerning independence estimating equations with multivariate binary data publication-title: Biometrics – volume: 52 start-page: 500 year: 1996 end-page: 511 article-title: Efficiency of regression estimates for clustered data publication-title: Biometrics – year: 2002 – volume: 92 start-page: 1342 year: 1997 end-page: 1350 article-title: Semiparametric efficiency and its implications on the design and analysis of group sequential studies publication-title: Journal of the American Statistical Association – year: 2000 – volume: 23 start-page: 939 year: 1994 end-page: 951 article-title: A cautionary note on inference for marginal regression models with longitudinal data and general correlated response data publication-title: Communications in Statistics Simulation and Computation – volume: 82 start-page: 407 year: 1995 end-page: 410 article-title: On the use of working correlation matrix in using generalized linear models for repeated measures publication-title: Biometrika – volume: 64 start-page: 191 year: 1977 end-page: 200 article-title: Group sequential methods in the design and analysis of clinical trials publication-title: Biometrika – volume: 73 start-page: 13 year: 1986 end-page: 22 article-title: Longitudinal data analysis using generalized linear models publication-title: Biometrika – volume: 132 start-page: 235 year: 1969 end-page: 244 article-title: Repeated significance tests on accumulating data publication-title: Journal of the Royal Statistical Society, Series A, General – volume: 50 start-page: 270 year: 1994 end-page: 278 article-title: Performance of generalized estimating equations in practical situations publication-title: Biometrics – volume: 35 start-page: 549 year: 1979 end-page: 556 article-title: A multiple testing procedure for clinical trials publication-title: Biometrics – ident: e_1_2_8_11_1 doi: 10.2307/2533218 – volume-title: PEST (Planning and Evaluation of Sequential Trials) year: 2000 ident: e_1_2_8_3_1 – ident: e_1_2_8_13_1 doi: 10.2307/2532890 – ident: e_1_2_8_6_1 doi: 10.1080/01621459.1997.10473654 – ident: e_1_2_8_17_1 – ident: e_1_2_8_7_1 doi: 10.1001/jama.300.15.1774 – ident: e_1_2_8_9_1 doi: 10.1080/03610919408813210 – ident: e_1_2_8_12_1 doi: 10.2307/2533336 – ident: e_1_2_8_15_1 doi: 10.2307/2343787 – volume-title: Group Sequential Methods with Applications to Clinical Trials year: 2000 ident: e_1_2_8_16_1 – ident: e_1_2_8_18_1 – ident: e_1_2_8_20_1 doi: 10.2307/2530245 – ident: e_1_2_8_8_1 doi: 10.1093/biomet/73.1.13 – ident: e_1_2_8_10_1 doi: 10.1093/biomet/82.2.407 – volume-title: East year: 2000 ident: e_1_2_8_2_1 – ident: e_1_2_8_5_1 doi: 10.1080/01621459.1997.10473655 – volume-title: S+seqtrial year: 2002 ident: e_1_2_8_4_1 – ident: e_1_2_8_14_1 doi: 10.1093/biomet/83.4.779 – ident: e_1_2_8_19_1 doi: 10.1093/biomet/64.2.191 |
SSID | ssj0011527 |
Score | 2.1621158 |
Snippet | In phase 3 clinical trials, ethical and financial concerns motivate sequential analyses in which the data are analyzed prior to completion of the entire... |
SourceID | proquest pubmed crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 5041 |
SubjectTerms | Clinical trials Clinical Trials, Phase III as Topic - economics Clinical Trials, Phase III as Topic - ethics Clinical Trials, Phase III as Topic - statistics & numerical data Correlation analysis Epidemiologic Research Design Estimating techniques group sequential methods Humans independent increments Longitudinal Studies Medical statistics Sampling Software Statistics as Topic - methods Violations |
Title | Violations of the independent increment assumption when using generalized estimating equation in longitudinal group sequential trials |
URI | https://api.istex.fr/ark:/67375/WNG-XDW7FNN3-6/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fsim.6306 https://www.ncbi.nlm.nih.gov/pubmed/25224560 https://www.proquest.com/docview/1628562981 https://www.proquest.com/docview/2169485763 https://www.proquest.com/docview/1622595035 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfQkNAkxEf5KgxkJARP6RLHcZJHBJSB1D4AY5V4sPw5qnXNWFuB9s7_zZ2dBA0VCfGUKL5EtnM-_2zf_Y6QZ5my2vNUJY45m3ChfaJhtZw4IVRhhAUIgfHOk6k4OOTvZ8Ws9arEWJjID9FvuOHICPYaB7jSq_3fpKGr-elI5IFtG121EA996Jmjsi5bK55QijIrOt7ZlO13L16aia5ip_7YBjMvo9Yw7Yxvki9dhaO3yclos9Yjc_EHl-P_tegWudGiUfoyqs9tcsUtB-TapD1vH5DrcVePxmClAdlFbBqpne-Qn5_nTetJRxtPAUnSeZ9Udw33Ju49UsDnoDQoSL9_dUuKvvbH9DgSXs8vnKVI9YHQGR67b5F8HN6niwazKW0sZu6iIf6ERtdvMEsLGhKOrO6Sw_GbT68OkjarQ2J4VYjEZopbzWtT5V5kKmUGEJuomHe1t4rrlNtSgR32ML8qx3VmlHOABG3qK1Ybn98jO8tm6R4Q6nPtvC5rVxjGi8xVtS9roXSR16Z0zA_Ji-4PS9NSnmPmjYWMZM1MQpdL7PIhedpLnkWajy0yz4OS9ALq_ATd4spCHk3fytnro3I8neYSBPc6LZKtRVjJDGNVBaurbGsxywTy9IC1h6r0xTDU8fxGLV2zCZ-AxWqR5sWQ3I_K2deFAY4GLJxCJYOK_bUV8uO7CV4f_qvgI7ILIDGQW7J0j-yszzfuMQCxtX4ShtwvJhoy9g |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELamTYJJiB_lV2GAkRA8pYudxEnEE2KUDtY-wMb6MMmyHXtUKwmsrUB75__mLk6ChoqEeGrUXCLHOZ-_2HffR8gzpgrt4lAFltsiiIV2gYav5cAKoRIjCoAQWO88nojRUfxumkw3yMu2FsbzQ3QLbjgy6niNAxwXpHd_s4YuZl8GIkK67S0U9Eb5gr0PHXcUa_VacY9SpCxpmWdDvtteeWku2sJu_bEOaF7GrfXEM7xBTtom-3yTs8FqqQfm4g82x_98ppvkegNI6SvvQbfIhi175Mq42XLvkWt-YY_6eqUe2UZ46tmdb5Ofn2ZVk0xHK0cBTNJZp6u7hGPjlx8pQHTwGzSk3z_bkmK6_Sk99ZzXswtbUGT7QPQMf9tvnn8crqfzCgWVVgWKd9G6BIX67G-ITHNaa44s7pCj4ZvD16OgEXYITJwlIiiYigsd5yaLnGAq5AZAm8i4s7krVKzDuEgVhGIHU6yysWZGWQtgsAhdxnPjortks6xKe59QF2nrdJrbxPA4YTbLXZoLpZMoN6nlrk9etK9Ymob1HMU35tLzNXMJXS6xy_vkaWf51TN9rLF5XntJZ6DOzzAzLk3k8eStnO4dp8PJJJJguNO6kWyCwkIyLFcVPM_Y2tOcCaTqgYAPTelOw2jHLRxV2mpV3wK-V5MwSvrknvfOri0coDTA4RAaWfvYX59Cftwf4--DfzV8Qq6ODscH8mB_8v4h2QbMWHNd8nCHbC7PV_YR4LKlflyPv18iczcQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfQJk2TEB_lqzDASAie0iWO4ySPiFE2oBUCxirtwfLnqFaasbYC7Z3_m7s4CRoqEuIpUXKJHOfu_LN99ztCnibKas9jFTnmbMSF9pGG2XLkhFCZERYgBOY7j8Zi_5C_mWSTJqoSc2ECP0S34IaWUftrNPAz63d_k4Yupl8HIkW27U0uwFYQEH3oqKOStlwrblGKPMla4tmY7bZPXhqKNrFXf6zDmZdhaz3uDK-T47bFIdzkdLBa6oG5-IPM8f8-6Qa51sBR-iLoz01yxc17ZGvUbLj3yNWwrEdDtlKPbCM4DdzOt8jPz9OqCaWjlacAJem0q6q7hHMTFh8pAHTQGhSk37-4OcVg-xN6EhivpxfOUuT6QOwMl923wD4Oz9NZheWUVhZLd9E6AYWG2G_wSzNaVxxZ3CaHw1efXu5HTVmHyPAiE5FNFLeal6ZIvUhUzAxANlEw70pvFdcxt7kCR-xhgFWO68Qo5wAK2tgXrDQ-vUM25tXc3SPUp9p5nZcuM4xniStKn5dC6SwtTe6Y75Pn7R-WpuE8x9IbMxnYmpmELpfY5X3ypJM8Czwfa2Se1UrSCajzU4yLyzN5NH4tJ3tH-XA8TiUI7rRaJBuXsJAJJqsKVhbJ2tssEUjUA-4emtLdBlvHDRw1d9WqfgXMVrM4zfrkblDOri0MgDSA4RgaWavYX79CfjwY4fH-vwo-Jlvv94by3cH47QOyDYCxJrpk8Q7ZWJ6v3EMAZUv9qLa-X38CNcg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Violations+of+the+independent+increment+assumption+when+using+generalized+estimating+equation+in+longitudinal+group+sequential+trials&rft.jtitle=Statistics+in+medicine&rft.au=Shoben%2C+Abigail+B.&rft.au=Emerson%2C+Scott+S.&rft.date=2014-12-20&rft.issn=0277-6715&rft.eissn=1097-0258&rft.volume=33&rft.issue=29&rft.spage=5041&rft.epage=5056&rft_id=info:doi/10.1002%2Fsim.6306&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_sim_6306 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0277-6715&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0277-6715&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0277-6715&client=summon |